Posted by Clinical Lab Products | Apr 4, 2004 | Cerebrovascular, Miscellaneous |
By Lisa Fratt Aspirin is the frontline therapy used to protect patients from cardiovascular disease and stroke. In the United States alone, 25 million to 30 million people take aspirin on a daily basis to prevent cardiovascular disease and strok
Read MorePosted by Clinical Lab Products | Apr 2, 2004 | Cancer, Cerebrovascular, Miscellaneous, Stroke |
By Renee DiIulio Proteomics will soon enable speedy, sensitive, specific diagnosis of ischemic stroke. This will result in rapid treatment and improved outcomes for patients. “The future, for the general physician, lies in genomics, or anal
Read MorePosted by Clinical Lab Products | Feb 10, 2004 | Cancer, Miscellaneous |
Pall Ultrafiltration Technology Simplifies Production of Vaccines Conjugate vaccines that protect infants and young children from infectious diseases will become more widely available now that the complicated and expensive production process has b
Read MorePosted by Clinical Lab Products | Jan 10, 2004 | Cancer, Miscellaneous |
ASH Meeting Addresses Developments in Treating Blood Disorders Approximately 20,000 physicians and scientists from around the world gathered for the 45th Annual Meeting of the American Society of Hematology (ASH), December 6–9, 2003, at the S
Read MorePosted by Clinical Lab Products | Dec 5, 2003 | Cancer, Miscellaneous |
By Susan L. Taylor, MS, MT (ASCP), MBA In September 2003, the VIDAS® D-Dimer New™ from bioMerieux was approved by the United States Food and Drug Administration (FDA) for use in excluding a diagnosis of deep-vein thrombosis (DVT) when used i
Read More